Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Electrocore (ECOR – Research Report) and Viking Therapeutics (VKTX – Research Report) with bullish sentiments.

Electrocore (ECOR)

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Electrocore yesterday and set a price target of $15.00. The company’s shares closed last Thursday at $6.09.

According to TipRanks.com, Vendetti has 0 stars on 0-5 stars ranking scale with an average return of -2.6% and a 32.0% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Guardion Health Sciences, Tenon Medical, Inc., and Sensus Healthcare.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Electrocore with a $15.00 average price target, implying a 141.5% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $15.00 price target.

See the top stocks recommended by analysts >>

Viking Therapeutics (VKTX)

In a report released yesterday, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Viking Therapeutics. The company’s shares closed last Thursday at $65.05.

According to TipRanks.com, Samimy is a 4-star analyst with an average return of 10.9% and a 48.0% success rate. Samimy covers the Healthcare sector, focusing on stocks such as Calliditas Therapeutics, Apellis Pharmaceuticals, and Jazz Pharmaceuticals.

Currently, the analyst consensus on Viking Therapeutics is a Strong Buy with an average price target of $106.17, implying a 50.6% upside from current levels. In a report issued on March 7, Jefferies also initiated coverage with a Buy rating on the stock with a $110.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ECOR:

• Electrocore’s Battle with Cyber Threats: Protecting Sensitive Data Amidst Rising Security Risks
• electroCore reports Q4 EPS (61c) vs. ($1.22) last year
• electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
• electroCore to Participate in Upcoming Investor Conferences
• electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024